Literature DB >> 20825805

A prospective, randomized, trial of phenobarbital versus benzodiazepines for acute alcohol withdrawal.

Gregory W Hendey1, Robert A Dery, Randy L Barnes, Brandy Snowden, Philippe Mentler.   

Abstract

OBJECTIVE: The aim of this study was to compare phenobarbital (PB) versus lorazepam (LZ) in the treatment of alcohol withdrawal in the emergency department (ED) and at 48 hours.
METHODS: Prospectively, randomized, consenting patients were assessed using a modified Clinical Institute Withdrawal Assessment (CIWA) score and given intravenous PB (mean, 509 mg) or LZ (mean, 4.2 mg). At discharge, LZ patients received chlordiazepoxide (Librium), and PB patients received placebo.
RESULTS: Of 44 patients, 25 received PB, and 19 LZ. Both PB and LZ reduced CIWA scores from baseline to discharge (15.0-5.4 and 16.8-4.2, P < .0001). There were no differences between PB and LZ in baseline CIWA scores (P = .3), discharge scores (P = .4), ED length of stay (267 versus 256 minutes, P = .8), admissions (12% versus 16%, P = .8), or 48-hour follow-up CIWA scores (5.8 versus 7.2, P = .6).
CONCLUSION: Phenobarbital and LZ were similarly effective in the treatment of mild/moderate alcohol withdrawal in the ED and at 48 hours.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20825805     DOI: 10.1016/j.ajem.2009.10.010

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  9 in total

1.  The Assessment and Management Practices of Acute Alcohol Withdrawal: Results of a Nationwide Survey of Critical Care Pharmacists.

Authors:  Susanne Dyal; Robert MacLaren
Journal:  Hosp Pharm       Date:  2018-04-13

2.  Patient Outcomes Associated With Phenobarbital Use With or Without Benzodiazepines for Alcohol Withdrawal Syndrome: A Systematic Review.

Authors:  Drayton A Hammond; Jordan M Rowe; Adrian Wong; Tessa L Wiley; Kristen C Lee; Sandra L Kane-Gill
Journal:  Hosp Pharm       Date:  2017-07-17

Review 3.  Are Alcohol Anti-relapsing and Alcohol Withdrawal Drugs Useful in Cannabinoid Users?

Authors:  Patrycja Kleczkowska; Irena Smaga; Małgorzata Filip; Magdalena Bujalska-Zadrozny
Journal:  Neurotox Res       Date:  2016-08-02       Impact factor: 3.911

4.  Future Considerations in Response to "Adjunctive Phenobarbital for Alcohol Withdrawal Syndrome: A Focused Literature Review".

Authors:  Rose Alwardi; Tony Rondinella; Andrea Quinn
Journal:  J Pharm Technol       Date:  2021-09-22

5.  Alcohol withdrawal syndrome in critically ill patients: protocolized versus nonprotocolized management.

Authors:  Jeremiah J Duby; Andrew J Berry; Paricheh Ghayyem; Machelle D Wilson; Christine S Cocanour
Journal:  J Trauma Acute Care Surg       Date:  2014-12       Impact factor: 3.313

6.  Phenobarbital Versus Lorazepam for Management of Alcohol Withdrawal Syndrome: A Retrospective Cohort Study.

Authors:  Fadi Hawa; Linsey Gilbert; Benjamin Gilbert; Vanessa Hereford; Aya Hawa; Alsadiq Al Hillan; Mark Weiner; Jeremy Albright; Caleb Scheidel; Ola Al-Sous
Journal:  Cureus       Date:  2021-02-11

Review 7.  Emergency Medicine Research Priorities for Early Intervention for Substance Use Disorders.

Authors:  Kathryn F Hawk; Rachel L Glick; Arthur R Jey; Sydney Gaylor; Jamie Doucet; Michael P Wilson; John S Rozel
Journal:  West J Emerg Med       Date:  2019-02-19

Review 8.  Prevention of alcohol withdrawal seizure recurrence and treatment of other alcohol withdrawal symptoms in the emergency department: a rapid review.

Authors:  Justin Jek-Kahn Koh; Madeline Malczewska; Mary M Doyle-Waters; Jessica Moe
Journal:  BMC Emerg Med       Date:  2021-11-06

9.  Research Needs for Inpatient Management of Severe Alcohol Withdrawal Syndrome: An Official American Thoracic Society Research Statement.

Authors:  Tessa L Steel; Majid Afshar; Scott Edwards; Sarah E Jolley; Christine Timko; Brendan J Clark; Ivor S Douglas; Amy L Dzierba; Hayley B Gershengorn; Nicholas W Gilpin; Dwayne W Godwin; Catherine L Hough; José R Maldonado; Anuj B Mehta; Lewis S Nelson; Mayur B Patel; Darius A Rastegar; Joanna L Stollings; Boris Tabakoff; Judith A Tate; Adrian Wong; Ellen L Burnham
Journal:  Am J Respir Crit Care Med       Date:  2021-10-01       Impact factor: 21.405

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.